Page last updated: 2024-08-21

pyrazines and aminopterin

pyrazines has been researched along with aminopterin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mertes, MP; Patel, NR1
O'Connor, OA1
Marchi, E; O'Connor, OA; Paoluzzi, L; Scotto, L; Seshan, VE; Zain, JM; Zinzani, PL1
Mangone, M; Marchi, E; O'Connor, OA; Zullo, K1

Reviews

1 review(s) available for pyrazines and aminopterin

ArticleYear
Novel agents in development for peripheral T-cell lymphoma.
    Seminars in hematology, 2010, Volume: 47 Suppl 1

    Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Depsipeptides; Drug Design; Drugs, Investigational; Histone Deacetylase Inhibitors; Humans; Immunologic Factors; Lenalidomide; Lymphoma, T-Cell, Peripheral; Purine Nucleosides; Pyrazines; Pyrimidinones; Salvage Therapy; Thalidomide

2010

Trials

1 trial(s) available for pyrazines and aminopterin

ArticleYear
Pralatrexate pharmacology and clinical development.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Dec-15, Volume: 19, Issue:24

    Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Depsipeptides; Disease-Free Survival; Drug Approval; Drug Synergism; Gemcitabine; Humans; Lymphoma, T-Cell; Male; Pyrazines; Treatment Outcome; United States; United States Food and Drug Administration

2013

Other Studies

2 other study(ies) available for pyrazines and aminopterin

ArticleYear
Synthesis of methylenetetrahydrofolic acid analogs.
    Journal of medicinal chemistry, 1966, Volume: 9, Issue:6

    Topics: Aminopterin; Chemistry, Organic; Enzymes; Imidazoles; Nucleotides; Organic Chemistry Phenomena; Pyrazines

1966
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Jul-15, Volume: 16, Issue:14

    Topics: Aminopterin; Animals; Apoptosis; Boronic Acids; Bortezomib; Caspase 8; Caspase 9; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lymphoma, T-Cell; Mice; Mice, SCID; Neoplasm Transplantation; Pyrazines; Xenograft Model Antitumor Assays

2010